Facebook Pixel Code
About Sickkids
About SickKids

October 7, 2011

Dr. David Malkin appointed Medical Director of POGO; Chair of Childhood Cancer Control at U of T

Dr. David Malkin has been appointed Medical Director of POGO (Pediatric Oncology Group of Ontario) and Chair in Childhood Cancer Control at the University of Toronto (U of T). He assumed his new roles August 1, 2011.

Malkin has a long-standing interest in biological, medical and ethical issues related to childhood cancer.  He is a Senior Staff Oncologist in Haematology/Oncology and Director of the Cancer Genetics Program at SickKids; Senior Scientist in the Genetics and Genome Biology Program at SickKids Research Institute; and a Professor of Paediatrics and Medical Biophysics at U of T. He has held national and international leadership positions in research, education and clinical practice.

POGO created the combined position of POGO Chair in Childhood Cancer Control and Medical Director so that Ontario would always have dedicated, seasoned, visionary leadership to ensure a well-integrated, evidence-based cancer delivery system for children.

“The POGO Chair must bring to the position not only an academic outlook and a unique grasp of research, education, clinical acumen and health-care delivery savvy, but also a rare ability to ignite a passion to work on behalf of the population and to inspire collaboration,” says Dr. Corin Greenberg, POGO’s Executive Director.

At a joint celebration of Malkin’s appointment, Dr. Catharine Whiteside, Dean of Medicine, U of T and Vice Provost for Relations with Health Care Institutions commented, “It is a great honour and pleasure to be [POGO’s] ally in this cause, and it is a great pleasure to have Dr. David Malkin as [POGO’s] Chair and shared leader in improving the health of children with cancer and improving the lives of their families.”

Founded in 1983, POGO has served as the Ministry of Health & Long-Term Care’s counsel on childhood cancer control. The organization works to ensure that all of Ontario’s children have equal access to state-of-the-art diagnosis, treatment and required ancillary services.